Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Polysomnographic effects of hypnotic drugs. A review.

Literature DB >> 8853211

Polysomnographic effects of hypnotic drugs. A review.

Abstract

This review aims at providing a critical assessment of the effects of the most widely used benzodiazepine (flurazepam, flunitrazepam, temazepam, triazolam) and non-benzodiazepine (zopiclone and zolpidem) hypnotic drugs, based on the recording of polysomnographic variables. In the light of newly acquired neurophysiological data on the microstructure of sleep, this paper reconsiders the problem of insomnia and the current ideas on polysomnography and hypnotic drugs.

Entities: Chemical Disease

Mesh：

Substances：

Year: 1996 PMID： 8853211 DOI： 10.1007/bf02246405

Source DB: PubMed Journal: Psychopharmacology (Berl) ISSN： 0033-3158 Impact factor: 4.530

89 in total

1. Ultradian dynamics of sleep after a single dose of benzodiazepine hypnotics.

Authors: A A Borbély; P Achermann
Journal: Eur J Pharmacol Date: 1991-03-19 Impact factor: 4.432

2. Dose response effects of zolpidem in normal geriatric subjects.

Authors: M B Scharf; D W Mayleben; M Kaffeman; R Krall; R Ochs
Journal: J Clin Psychiatry Date: 1991-02 Impact factor: 4.384

3. Modulation of delta activity by hypnotics in middle-aged subjects: studies with a benzodiazepine (flurazepam) and a cyclopyrrolone (zopiclone).

Authors: N A Wright; A Belyavin; R G Borland; A N Nicholson
Journal: Sleep Date: 1986-06 Impact factor: 5.849

4. The cyclic alternating pattern as a physiologic component of normal NREM sleep.

Authors: M G Terzano; D Mancia; M R Salati; G Costani; A Decembrino; L Parrino
Journal: Sleep Date: 1985 Impact factor: 5.849

Review 5. Zopiclone, the third generation hypnotic: a clinical overview.

Authors: B Musch; F Maillard
Journal: Int Clin Psychopharmacol Date: 1990-04 Impact factor: 1.659

6. Effect of zolpidem on sleep in insomniac patients.

Authors: J M Monti
Journal: Eur J Clin Pharmacol Date: 1989 Impact factor: 2.953

7. Biopsychobehavioral correlates of insomnia. IV: Diagnosis based on DSM-III.

Authors: T L Tan; J D Kales; A Kales; C R Soldatos; E O Bixler
Journal: Am J Psychiatry Date: 1984-03 Impact factor: 18.112

8. Comparison of lorazepam and flurazepam as hypnotic agents in chronic insomniacs.

Authors: D J McClure; J Walsh; H Chang; A Olah; R Wilson; J C Pecknold
Journal: J Clin Pharmacol Date: 1988-01 Impact factor: 3.126

9. Self-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia.

Authors: M A Carskadon; W C Dement; M M Mitler; C Guilleminault; V P Zarcone; R Spiegel
Journal: Am J Psychiatry Date: 1976-12 Impact factor: 18.112

10. Residual effects of hypnotics: triazolam, flurazepam, and nitrazepam.

Authors: C Ogura; K Nakazawa; K Majima; K Nakamura; H Ueda; Y Umezawa; W M Wardell
Journal: Psychopharmacology (Berl) Date: 1980 Impact factor: 4.530

22 in total

1. Use of non-benzodiazepine sedative hypnotics and risk of falls in older men.

Authors: Susan J Diem; Susan K Ewing; Katie L Stone; Sonia Ancoli-Israel; Susan Redline; Kristine E Ensrud
Journal: J Gerontol Geriatr Res Date: 2014-07-01

Review 2. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.

Authors: K J Holm; K L Goa
Journal: Drugs Date: 2000-04 Impact factor: 9.546

3. Effects of onion extract containing concentrated cysteine sulfoxides on sleep quality: a randomized, double-blind, placebo-controlled, crossover study.

Authors: Yuya Nakayama; Miki Makita; Satomi Nozaki; Yosuke Kikuchi
Journal: Food Sci Biotechnol Date: 2020-10-06 Impact factor: 2.391

Review 4. Sleep disorders in the elderly.

Authors: R Asplund
Journal: Drugs Aging Date: 1999-02 Impact factor: 3.923

5. Trazodone for the treatment of fibromyalgia: an open-label, 12-week study.

Authors: Piedad Morillas-Arques; Carmen Ma Rodriguez-Lopez; Rocio Molina-Barea; Fernando Rico-Villademoros; Elena P Calandre
Journal: BMC Musculoskelet Disord Date: 2010-09-10 Impact factor: 2.362

Review 6. Zaleplon: a review of its use in the treatment of insomnia.

Authors: M Dooley; G L Plosker
Journal: Drugs Date: 2000-08 Impact factor: 9.546

7. Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies.

Authors: D Alan Lankford; Bruce C Corser; Yan-Ping Zheng; Zhengrong Li; Duane B Snavely; Christopher R Lines; Steve Deacon
Journal: Sleep Date: 2008-10 Impact factor: 5.849

8. Sleep and sleep disorders in chronic users of zopiclone and drug-free insomniacs.

Authors: Børge Sivertsen; Siri Omvik; Ståle Pallesen; Inger Hilde Nordhus; Bjørn Bjorvatn
Journal: J Clin Sleep Med Date: 2009-08-15 Impact factor: 4.062

9. Short-term treatment with gaboxadol improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia.

Authors: J Lundahl; L Staner; C Staner; H Loft; S Deacon
Journal: Psychopharmacology (Berl) Date: 2007-07-27 Impact factor: 4.530

10. Consensus on drug treatment, definition and diagnosis for insomnia.

Authors: E Estivill; A Bové; D García-Borreguero; J Gibert; J Paniagua; G Pin; F J Puertas; R Cilveti
Journal: Clin Drug Investig Date: 2003 Impact factor: 2.859